Welcome Address | New Faculty Panel | Clinician Collaborators — Stories of Invention & Inspiration | Industry Insider Panel — Driving Health Translation & Entrepreneurship | Inventing the Future of Medicine — Special Talks & Panels | 50 Years of Discovery and Invention: Bioengineering Recognition & Awards | Keynote Address
Cecilia Giachelli, Ph.D.
W. Hunter and Dorothy Simpson Endowed Chair of Bioengineering
Dr. Cecilia Giachelli, also adjunct professor in pathology and in oral sciences, is internationally recognized for her work in the area of vascular calcification leading to the development of molecular and cellular therapies for chronic kidney disease and atherosclerosis.
Michael Bragg, Ph.D.
Frank & Julie Jungers Dean of Engineering
As chief academic officer of the College of Engineering, Dr. Michael Bragg leads more than 240 faculty and 6,800 students. He is an international expert on the effect of ice accretion on aircraft aerodynamics and flight safety.
Paul G. Ramsey, Ph.D.
CEO of UW Medicine, Executive Vice President for Medical Affairs and Dean of the School of Medicine
Dr. Paul Ramsey has served as UW Medicine’s senior executive leader since 1997. His research has focused on the development of methods to assess physicians’ clinical competence. UW Medicine includes the UW School of Medicine, four hospitals, a network of primary care clinics, a large physician practice plan and an air ambulance service.
New Faculty Panel
Andre Berndt, Ph.D. (January 2017)
Dr. Andre Berndt, assistant professor, develops biosensors for optogenetics with the goal of detecting and understanding brain disorders such as autism, schizophrenia and depression.
Jennifer Davis, Ph.D. (August 2015)
Dr. Jennifer Davis, assistant professor of pathology and bioengineering, uses genetic engineering to study the biology of cardiac wound healing and repair. She works to reduce the effect of scar tissue and enhance repair of heart muscle.
Hao Yuan Kueh, Ph.D. (August 2016)
Dr. Hao Yuan Kueh, assistant professor, is an expert in systems and quantitative immunology. He lays foundations for engineering immune cells to fight cancer and other life-threatening diseases.
Amy Orsborn, Ph.D. (September 2019)
Dr. Amy Orsborn will join UW as the Clare Boothe Luce Assistant Professor in electrical engineering and in bioengineering. She works to improve brain-machine interfaces to restore motor function to people with limb loss, stroke or spinal injury.
Kelly Stevens, Ph.D. (January 2016)
Dr. Kelly Stevens, assistant professor in bioengineering and in pathology, works to build synthetic human tissues from stem cells, and to remotely control these tissues after implantation in a patient.
Azadeh Yazdan-Shahmorad, Ph.D. (September 2017)
Dr. Azadeh Yazdan-Shahmorad, theWashington Research Foundation Innovation Assistant Professor of Neuroengineering in the departments of bioengineering and electrical engineering, works to develop novel neural technologies and therapies to address stroke rehabilitation.
Moderator: Brynn Olden, BioE predoctoral student
Brynn Olden is an NSF Graduate Research Fellow and Ph.D. candidate. She is developing novel biomaterials for use in adoptive T-cell therapy manufacturing with BioE Professor Suzie Pun.
Clinician Collaborators — Stories of Invention & Inspiration
Tueng Shen, M.D., Ph.D., UW Ophthalmology
With BioE Professor Ruikang (Ricky) Wang, Ph.D.
Dr. Tueng Shen is a cataract and cornea surgeon at the Eye Institute at Harborview Medical Center. She is also a UW professor of ophthalmology and adjunct professor of both global health and bioengineering. Dr. Ricky Wang is a professor of bioengineering and ophthalmology, and the WRF/David and Nancy Auth Innovator of Bioengineering.
Samuel Browd, Ph.D., UW Neurological Surgery
With BioE Associate Professor Barry Lutz, Ph.D.
Dr. Samuel Browd is an attending neurosurgeon at Seattle Children’s Hospital, Harborview Medical Center and the UW Medical Center. Dr. Barry Lutz is the Pilcher Faculty Fellow and manipulates principles of flow, transport and reaction to engineer medical devices for disease detection and treatment.
Nathan White, M.D., UW Emergency Medicine
With Robert F. Rushmer Professor in Bioengineering Suzie Pun, Ph.D.
Dr. Nathan White is a board certified physician in the Emergency Department at Harborview; a UW assistant professor of emergency medicine; and adjunct professor of bioengineering and mechanical engineering. Dr. Suzie Pun is the Robert F. Rushmer Professor and her research includes development of new materials for drug delivery and an injectable polymer that can help stop uncontrolled bleeding.
Industry Insider Panel — Driving Health Care Forward: Translation & Entrepreneurship
Leslie Alexandre, Dr.P.H.
President & CEO Life Science Washington
Dr. Leslie Alexandre is a 30-year veteran of the life science and health care industries. In her current role, she advocates for the support and growth of Washington’s life science industry. She also serves on UW’s Industry Advisory Board.
Hugh Chang, M.S. (UW BioE ’05)
Director, Strategy, Planning and Management for Global Development, Bill & Melinda Gates Foundation
In his role at the Gates Foundation, Hugh Chang works closely with the leadership team to guide the foundation’s global activities, including Global Health. He is a BioE Advisory Board member.
Wayne Gombotz, Ph.D. (UW BioE ’88, M.S. ’85)
Chief Development Officer, Immune Design Corp.
Dr. Wayne Gombotz has over 20 years of executive management and leadership roles in the biopharmaceutical industry. He is a BioE Advisory Board member and affiliate assistant professor.
Cameron Pollock, M.B.A.
Advisor, Physio-Control, now part of Stryker
Cameron Pollock served as executive vice president and chief marketing officer at Physio-Control for 11 years, until taking on an advisor role last month. He has nearly 30 years’ experience in biomedical sales and marketing.
David Zion, M.S.
V.P., Ultrasound R&D at Philips Health Systems
David Zion joined Philips in 2002, and has held leadership positions in clinical applications, software and research and development. He earned engineering degrees from MIT and Stanford.
Moderator: Matthew O’Donnell, Ph.D.
UW BioE Professor, Dean Emeritus of the College of Engineering
Dr. Matthew O’Donnell is a professor in the Department of Bioengineering and is known for his contributions to biomedical ultrasonics and real-time ultrasound imaging technologies. He is an elected fellow of the National Academy of Engineers and the Washington State Academy of Sciences.
Inventing the Future of Medicine — Special Talks & Panels
David Auth, Ph.D.
Founder and CEO of Heart Technology, Inc.; Affiliate Professor of Bioengineering
Dr. David Auth was a UW professor of electrical engineering from 1969 to 1982, and has been a UW affiliate professor in bioengineering since 1985. He is an elected member of the National Academy of Engineering, and is recognized for the invention and application of minimally invasive devices to treat gastrointestinal bleeding and coronary artery blockages, including endoscopes and catheters. He is known for inventing the widely used Rotablator, a minimally invasive tool that removes calcified plaque from coronary arteries.
Lee Huntsman, Ph.D.
UW President Emeritus; Professor Emeritus of Bioengineering; former Director of the UW Center for Bioengineering
Dr. Lee Huntsman joined the UW in 1968, conducting research in bioengineering from its earliest days. He served as director of the UW Center for Bioengineering from 1980-1996 and laid the groundwork for transitioning to a department. He later served as provost and vice president for academic affairs, and UW president. He is a founding fellow of the American Institute of Medical and Biological Engineering, a fellow of the Biomedical Engineering Society and the American Association for the Advancement of Science, and an inductee in the Washington Life Science Hall of Fame.
50 Years of Discovery and Invention: Bioengineering Recognition and Awards
Paul Yager, Ph.D.
UW BioE Professor of Bioengineering and former chair
Dr. Paul Yager is an elected member of the National Academy of Inventors and the Washington State Academy of Sciences. In 2012, he was recognized by Seattle Magazine’s Top Doctors issue for his groundbreaking work on medical devices for global health.
Buddy Ratner, Ph.D.
UW Professor of Bioengineering and Chemical Engineering, and the Michael L. & Myrna Darland Endowed Chair in Technology Commercialization
Dr. Buddy Ratner also is Director of UW Engineered Biomaterials Engineering Research Center. In 1984, he launched and led the National Institutes of Health-funded National ESCA and Surface Analysis Center for Biomedical Problems (NESAC/BIO), now world-renowned for its work. Dr. Ratner is an elected member of the National Academy of Engineering.
Keynote Address — Engineering Medicine: Decades of Transformation and the Promise of Healthy Longevity
Roderic I. Pettigrew
CEO and Executive Dean of EnHealth
During the past five decades, many changes have taken place across the bioengineering, biomedical research, and translational science landscape. In particular, the integration of engineering, and the physical and biological sciences has resulted in (1) significant progress in the understanding of the cellular and molecular mechanisms that underlie disease, (2) amazing advances in medical diagnostics, (3) remarkable improvements in therapeutics, and (4) an enhanced focus on preventative strategies. A vision that emerged early in the 21st century was to move beyond the reactive medical paradigm of the 20th century where the focus was on curing symptomatic disease, to a proactive paradigm that is focused on maintaining wellness and striving for precision in earlier diagnosis and treatment of disease. Remarkable progress has been made in areas such as biosensors, biomaterials and tissue engineering/regenerative medicine, drug and gene delivery systems, microfluidics, and nanotechnology, producing next generation technologies that have markedly improved medical diagnostics and therapeutic interventions. These innovations have also enhanced our ability to bring healthcare to all who need it, in particular those areas that are traditionally underserved, such as rural locales and developing countries, though this remains a goal in great need of sustained pursuit and development.
As we move further into the 21st Century, engineering converged with the life sciences and medicine holds the exciting promise of a deep transformation of medical education and translational research where physicians will be trained to be invention minded. This promises to be a more efficient way to help solve both common and vexing healthcare problems. In so doing, there is even greater hope of achieving the grandest challenge of sustained good health throughout the entirety of our lifetimes.
Roderic Ivan Pettigrew, Ph.D., M.D., serves as CEO of Engineering Health (EnHealth) and executive dean for Engineering Medicine (EnMed) at Texas A&M and Houston Methodist Hospital. Dr. Pettigrew also holds the endowed Robert A. Welch Chair in Medical Science. He was the founding Director of the U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the NIH (2002-2017).
His new undertaking is EnHealth, the world’s first initiative to holistically integrate engineering into all of the colleges of a university that are a part of the health care enterprise. EnMed is the first constituent program, creating a new school that integrates engineering into medical training to develop students/physicians who invent solutions to healthcare problems. Of note, an invention is required of each EnMed graduate.
Dr. Pettigrew was the founding director of the National Institute of Biomedical Imaging and Bioengineering. Under his guidance, NIBIB became internationally recognized for its global leadership in developing and accelerating the application of transformative health care technologies. Prior to his appointment at the NIH, Dr. Pettigrew was a professor of radiology and medicine (cardiology) at Emory University, professor of bioengineering at the Georgia Institute of Technology and director of the Emory Center for Magnetic Resonance Research at the Emory University School of Medicine.
An MIT graduate (Ph.D. ’77) who finished his medical training in Nuclear Medicine at UCSD (’83), he is known internationally for his pioneering work involving four-dimensional imaging of the cardiovascular system using magnetic resonance (MRI). Dr. Pettigrew’s current research focuses on integrated imaging and predictive modeling of coronary atherosclerotic disease.
Dr. Pettigrew is an elected member of both the National Academy of Medicine and the National Academy of Engineering; he was the first scientist at the NIH with this accomplishment. He also has been elected to the National Academy of Sciences, India. Some of his other awards include the Pritzker Distinguished Achievement Award of the Biomedical Engineering Society, the Distinguished Service Award of the National Medical Association, the Pierre Galletti Award of the American Institute of Medical and Biological Engineering and the Distinguished Service Medal of the International Society of Magnetic Resonance in Medicine.
Stories of Impact
(click and you’ll be taken to bioe.uw.edu)